Compare PTGX & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | ONDS |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.8B |
| IPO Year | 2016 | 2015 |
| Metric | PTGX | ONDS |
|---|---|---|
| Price | $82.25 | $11.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $99.20 | $19.00 |
| AVG Volume (30 Days) | 600.9K | ★ 80.1M |
| Earning Date | 01-01-0001 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 404.32 | 30.68 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,192,694.00 |
| Revenue This Year | N/A | $582.00 |
| Revenue Next Year | $501.99 | $267.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.70 | $0.57 |
| 52 Week High | $96.54 | $15.28 |
| Indicator | PTGX | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 53.72 |
| Support Level | $80.40 | $8.70 |
| Resistance Level | $83.40 | $10.64 |
| Average True Range (ATR) | 3.21 | 1.10 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 45.85 | 90.99 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.